The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Recently, the FDA reported that patients using Actos for a year or longer have a substantially increased risk of bladder cancer. Because of this increased risk current and past users of Actos should be aware of the symptoms of bladder cancer and the steps that should be taken if you are experience symptoms.

Common symptoms of bladder cancer include blood in the urine, changes in the color of your urine, pain during urination and changes in your urination habits. If you took Actos and have experienced these symptoms, it is vital to your health to be properly screened for bladder cancer.

There are several tests that are used by urologists, oncologists and other doctors to diagnose bladder cancer. These procedures include:

Cystoscopy: During a cystoscopy, your doctor inserts a narrow tube (known as a cystoscope) through your urethra. The cystoscope has a lens and lighting system that allows your doctor to see the inside of your urethra and bladder. The test is not painful and your doctor will provide a local anesthetic to ensure your comfort.

Biopsy: During the cystoscopy, your doctor may collect a small cell sample (biopsy) for further testing. The cells will be sent to a lab and studied. The reports of the study will then be provided to you.

Urine cytology: This procedure involves sampling your urine to check for cancer cells.

Imaging tests: Imaging tests allow your doctor to examine the structures of your urinary tract. You may receive a dye, which can be injected into a vein.

These tests can definitively determine whether you have bladder cancer. Speak to your doctor about being tested if you took Actos and suspect that you may have bladder cancer to determine the right test for your. Early testing and early diagnoses are key to protecting your health.

Comments for this article are closed.